Literature DB >> 28522332

Towards measles elimination in Italy: Virological surveillance and genotypes trend (2013-2015).

Fabio Magurano1, Melissa Baggieri2, Antonietta Filia3, Martina Del Manso4, Tiziana Lazzarotto5, Antonella Amendola6, Pierlanfranco D'Agaro7, Maria Chironna8, Filippo Ansaldi9, Stefania Iannazzo10, Paola Bucci11, Antonella Marchi12, Loredana Nicoletti13.   

Abstract

In accordance with the goal of the World Health Organization Regional Office for Europe, the Italian National Measles and Rubella Elimination Plan aimed to interrupt indigenous measles transmission in Italy by the end of 2015. However, from 2013 to 2015, Italy experienced high measles burden with 4902 measles cases (49.3% laboratory-confirmed) reported to the enhanced measles surveillance system (cumulative incidence in the triennium reference period: 2.4/100,000 population). The measles elimination goal was not reached. Laboratory surveillance of measles circulating genotypes is performed by the Measles and Rubella National Reference Laboratory (NRL) at the Italian National Institute of Health (Istituto Superiore di Sanità - ISS), in Rome. Samples received from 1 January 2013-31 December 2015 were analysed. Those positive for measles genome by molecular tests were sequenced and phylogenetically analysed. Phylogenetic analysis performed by NRL identified that genotypes D4 and D8 were endemic and co-circulated in 2011-2013: study results show that genotype D4 disappeared during 2013. Sporadic cases were associated to genotype B3 during 2011-2013, which became endemic in Italy during 2014 and co-circulated with D8 until 2015. Sporadic cases were found belonging to genotypes D9 and H1 all over the period in exam. Similar trend has been observed in European WHO Region.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Elimination; Genotyping; Measles; Measles outbreak; Phylogenetic analysis; Rubella

Mesh:

Substances:

Year:  2017        PMID: 28522332     DOI: 10.1016/j.virusres.2017.05.009

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  6 in total

1.  Use of FTA Cards To Transport Throat Swabs and Oral Fluid Samples for Molecular Detection and Genotyping of Measles and Rubella Viruses.

Authors:  Bettina Bankamp; Carolyn Sein; Elisabeth Pukuta Simbu; Raydel Anderson; Emily Abernathy; Min-Hsin Chen; Jean-Jacques Muyembe Tamfum; Kathleen A Wannemuehler; Diane Waku-Kouomou; Elena N Lopareva; Joseph P Icenogle; Paul A Rota; James L Goodson
Journal:  J Clin Microbiol       Date:  2019-04-26       Impact factor: 5.948

2.  Ongoing large measles outbreak with nosocomial transmission in Milan, northern Italy, March-August 2017.

Authors:  Antonella Amendola; Silvia Bianchi; Elena R Frati; Giulia Ciceri; Marino Faccini; Sabrina Senatore; Daniela Colzani; Anna Lamberti; Melissa Baggieri; Danilo Cereda; Maria Gramegna; Loredana Nicoletti; Fabio Magurano; Elisabetta Tanzi
Journal:  Euro Surveill       Date:  2017-08-17

3.  Molecular Epidemiology of B3 and D8 Measles Viruses through Hemagglutinin Phylogenetic History.

Authors:  Silvia Bianchi; Marta Canuti; Giulia Ciceri; Maria Gori; Daniela Colzani; Marco Dura; Beatrice Marina Pennati; Melissa Baggieri; Fabio Magurano; Elisabetta Tanzi; Antonella Amendola
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

4.  Measles-Related Hospitalizations in Italy, 2004-2016: The Importance of High Vaccination Coverage.

Authors:  Fabiana Fiasca; Stefano Necozione; Leila Fabiani; Marianna Mastrodomenico; Antonella Mattei
Journal:  Ann Glob Health       Date:  2019-03-19       Impact factor: 2.462

5.  Measles surveillance activities in the Metropolitan Area of Milan during 2017-2018.

Authors:  S Bianchi; M Faccini; A Lamberti; S Senatore; G Ciceri; E R Frati; D Colzani; M Gori; D Cereda; M Gramegna; F Auxilia; E Tanzi; A Amendola
Journal:  J Prev Med Hyg       Date:  2019-12-20

6.  Measles among healthcare workers in Italy: is it time to act?

Authors:  Valentina Baccolini; Alessandro Sindoni; Giovanna Adamo; Annalisa Rosso; Azzurra Massimi; Antonino Bella; Antonietta Filia; Fabio Magurano; Carolina Marzuillo; Paolo Villari; Corrado De Vito
Journal:  Hum Vaccin Immunother       Date:  2020-03-25       Impact factor: 3.452

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.